MYGN NASDAQ
Myriad Genetics, Inc.
1W: +8.0%
1M: -23.0%
3M: -8.9%
YTD: -36.3%
1Y: -12.1%
3Y: -79.0%
5Y: -85.7%
$3.82
-0.09 (-2.30%)
Weekly Expected Move ±11.2%
$3
$3
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$829M
Revenue
-0.3% YoY
$-400M
Net Income
-294.4% YoY
$-17M
Free Cash Flow
+51.4% YoY
68.7%
Gross Margin
-12.6%
Op. Margin
-17.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-74.8%
ROA-46.1%
ROIC-70.8%
Valuation
P/E-0.9
P/B1.1
EV/EBITDA-1.4
Leverage
Debt/Equity0.57
Current Ratio2.49
Interest Cov.-28.0x
Quality Scores
Piotroski F5/9
Altman Z-1.77
Beneish M-5.52